124 related articles for article (PubMed ID: 37343073)
1. CCRL2 Expression by Specialized Lung Capillary Endothelial Cells Controls NK-cell Homing in Lung Cancer.
Sozio F; Schioppa T; Laffranchi M; Salvi V; Tamassia N; Bianchetto-Aguilera FM; Tiberio L; Bonecchi R; Bosisio D; Parmentier M; Bottazzi B; Leone R; Russo E; Bernardini G; Garofalo S; Limatola C; Gismondi A; Sciumè G; Mantovani A; Del Prete A; Sozzani S
Cancer Immunol Res; 2023 Sep; 11(9):1280-1295. PubMed ID: 37343073
[TBL] [Abstract][Full Text] [Related]
2. The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance.
Del Prete A; Sozio F; Schioppa T; Ponzetta A; Vermi W; Calza S; Bugatti M; Salvi V; Bernardini G; Benvenuti F; Vecchi A; Bottazzi B; Mantovani A; Sozzani S
Cancer Immunol Res; 2019 Nov; 7(11):1775-1788. PubMed ID: 31484658
[TBL] [Abstract][Full Text] [Related]
3. Expression, regulation, and function of atypical chemerin receptor CCRL2 on endothelial cells.
Monnier J; Lewén S; O'Hara E; Huang K; Tu H; Butcher EC; Zabel BA
J Immunol; 2012 Jul; 189(2):956-67. PubMed ID: 22696441
[TBL] [Abstract][Full Text] [Related]
4. Molecular Basis for CCRL2 Regulation of Leukocyte Migration.
Schioppa T; Sozio F; Barbazza I; Scutera S; Bosisio D; Sozzani S; Del Prete A
Front Cell Dev Biol; 2020; 8():615031. PubMed ID: 33363177
[TBL] [Abstract][Full Text] [Related]
5. Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties.
Yoshimura T; Oppenheim JJ
Exp Cell Res; 2011 Mar; 317(5):674-84. PubMed ID: 21056554
[TBL] [Abstract][Full Text] [Related]
6. Exploring CCRL2 chemerin binding using accelerated molecular dynamics.
Bufano M; Laffranchi M; Sozzani S; Raimondo D; Silvestri R; Coluccia A
Proteins; 2022 Sep; 90(9):1714-1720. PubMed ID: 35437825
[TBL] [Abstract][Full Text] [Related]
7. Chemokine (CC-motif) receptor-like 2 mRNA is expressed in hepatic stellate cells and is positively associated with characteristics of non-alcoholic steatohepatitis in mice and men.
Zimny S; Pohl R; Rein-Fischboeck L; Haberl EM; Krautbauer S; Weiss TS; Buechler C
Exp Mol Pathol; 2017 Aug; 103(1):1-8. PubMed ID: 28600126
[TBL] [Abstract][Full Text] [Related]
8. Endothelial CCRL2 induced by disturbed flow promotes atherosclerosis via chemerin-dependent β2 integrin activation in monocytes.
Tang C; Chen G; Wu F; Cao Y; Yang F; You T; Liu C; Li M; Hu S; Ren L; Lu Q; Deng W; Xu Y; Wang G; Jo H; Zhang Y; Wu Y; Zabel BA; Zhu L
Cardiovasc Res; 2023 Aug; 119(9):1811-1824. PubMed ID: 37279540
[TBL] [Abstract][Full Text] [Related]
9. Chemokine (C-C Motif) Receptor-Like 2 is not essential for lung injury, lung inflammation, or airway hyperresponsiveness induced by acute exposure to ozone.
Malik F; Cromar KR; Atkins CL; Price RE; Jackson WT; Siddiqui SR; Spencer CY; Mitchell NC; Haque IU; Johnston RA
Physiol Rep; 2017 Dec; 5(24):. PubMed ID: 29242308
[TBL] [Abstract][Full Text] [Related]
10. Studies with neutralizing antibodies suggest CXCL8-mediated neutrophil activation is independent of C-C motif chemokine receptor-like 2 (CCRL2) ligand binding function.
Su Z; Brooks J; Pelker J; Andreyeva T; Sobon H; Gifford R; Powers M; Wang J; Dower C; Hegen M; Messing D; Sheehan AD; Brennan JJ
PLoS One; 2023; 18(1):e0280590. PubMed ID: 36662882
[TBL] [Abstract][Full Text] [Related]
11. CCRL2 promotes antitumor T-cell immunity via amplifying TLR4-mediated immunostimulatory macrophage activation.
Yin W; Li Y; Song Y; Zhang J; Wu C; Chen Y; Miao Y; Lin C; Lin Y; Yan D; Chen J; He R
Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33846258
[TBL] [Abstract][Full Text] [Related]
12. CCRL2 Modulates Physiological and Pathological Angiogenesis During Retinal Development.
Ben Dhaou C; Del Prete A; Sozzani S; Parmentier M
Front Cell Dev Biol; 2021; 9():808455. PubMed ID: 35004698
[TBL] [Abstract][Full Text] [Related]
13. Expression of CCRL2 Inhibits Tumor Growth by Concentrating Chemerin and Inhibiting Neoangiogenesis.
Al Delbany D; Robert V; Dubois-Vedrenne I; Del Prete A; Vernimmen M; Radi A; Lefort A; Libert F; Wittamer V; Sozzani S; Parmentier M
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638484
[TBL] [Abstract][Full Text] [Related]
14. The Atypical Receptor CCRL2 (C-C Chemokine Receptor-Like 2) Does Not Act As a Decoy Receptor in Endothelial Cells.
Mazzotti C; Gagliostro V; Bosisio D; Del Prete A; Tiberio L; Thelen M; Sozzani S
Front Immunol; 2017; 8():1233. PubMed ID: 29056935
[TBL] [Abstract][Full Text] [Related]
15. Signaling Properties of Chemerin Receptors CMKLR1, GPR1 and CCRL2.
De Henau O; Degroot GN; Imbault V; Robert V; De Poorter C; Mcheik S; Galés C; Parmentier M; Springael JY
PLoS One; 2016; 11(10):e0164179. PubMed ID: 27716822
[TBL] [Abstract][Full Text] [Related]
16. Absence of the Non-Signalling Chemerin Receptor CCRL2 Exacerbates Acute Inflammatory Responses
Regan-Komito D; Valaris S; Kapellos TS; Recio C; Taylor L; Greaves DR; Iqbal AJ
Front Immunol; 2017; 8():1621. PubMed ID: 29209334
[TBL] [Abstract][Full Text] [Related]
17. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis.
Zabel BA; Nakae S; Zúñiga L; Kim JY; Ohyama T; Alt C; Pan J; Suto H; Soler D; Allen SJ; Handel TM; Song CH; Galli SJ; Butcher EC
J Exp Med; 2008 Sep; 205(10):2207-20. PubMed ID: 18794339
[TBL] [Abstract][Full Text] [Related]
18. The miR-561-5p/CX
Chen EB; Zhou ZJ; Xiao K; Zhu GQ; Yang Y; Wang B; Zhou SL; Chen Q; Yin D; Wang Z; Shi YH; Gao DM; Chen J; Zhao Y; Wu WZ; Fan J; Zhou J; Dai Z
Theranostics; 2019; 9(16):4779-4794. PubMed ID: 31367257
[TBL] [Abstract][Full Text] [Related]
19. Nonredundant role of CCRL2 in lung dendritic cell trafficking.
Otero K; Vecchi A; Hirsch E; Kearley J; Vermi W; Del Prete A; Gonzalvo-Feo S; Garlanda C; Azzolino O; Salogni L; Lloyd CM; Facchetti F; Mantovani A; Sozzani S
Blood; 2010 Oct; 116(16):2942-9. PubMed ID: 20606167
[TBL] [Abstract][Full Text] [Related]
20. Chemerin partly mediates tumor-inhibitory effect of all-trans retinoic acid via CMKLR1-dependent natural killer cell recruitment.
Song Y; Yin W; Dan Y; Sheng J; Zeng Y; He R
Immunology; 2019 Jul; 157(3):248-256. PubMed ID: 31063220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
